Femoropatellar Osteoarthritis and Trochlear Femoral Bone Defect due to Giant Cell Tumor of the Knee: A Selected Patellofemoral Joint Arthroplasty and Reconstructive Technique: A Case Report.
Journal
JBJS case connector
ISSN: 2160-3251
Titre abrégé: JBJS Case Connect
Pays: United States
ID NLM: 101596828
Informations de publication
Date de publication:
Historique:
entrez:
12
2
2020
pubmed:
12
2
2020
medline:
12
1
2021
Statut:
ppublish
Résumé
A 35-year-old man with a giant cell tumor involving the lateral condyle and trochlea of the right distal femur underwent curettage of the lesion and cement grafting, which resulted in symptomatic patellofemoral osteoarthritis after more than 4 years. A standard follow-up excluded recurrence, whereas infection was ruled out while investigating the symptoms. Finally, a patellofemoral resurfacing prosthesis was implanted while filling the bone defects with tantalum cones. A "tailored" surgical technique with a selected patellofemoral joint arthroplasty could be used in oncologic setting to save further bone stock for possible revisions while permitting full and quick clinical recovery.
Identifiants
pubmed: 32044787
doi: 10.2106/JBJS.CC.19.00378
pii: 01709767-202003000-00023
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0378Références
Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk for recurrence. Clin Orthop Relat Res. 2011;469(2):591-9.
Cooper AS, Travers B. Surgical Essays. London: Cox Longman & Co; 1818.178-9.
Jaffe HL, Portis RB. Giant cell tumor of bone. Its pathologic appearance, grading. Supposed variants and treatment. Arch Pathol. 1940;30:993.
Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, Liu W. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am. 2012. 94(5):461-7.
Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Follerås G. Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008. 79(1):86-93
Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM; Canadian Sarcoma Group. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002;397:248-58.
Kay RM, Eckardt JJ, Seeger LL, Mirra JM, Hak DJ. Pulmonary metastasis of benign giant cell tumor of bone. Six histologically confirmed cases, including one of spontaneous regression. Clin Orthop Relat Res. 1994(302):219-30.
Kitano K, Shiraishi T, Okabayashi K, Iwasaki A, Kawahara K, Shirakusa T. A lung metastasis from giant cell tumor of bone at eight years after primary resection. Jpn J Thorac Cardiovasc Surg. 1999;47(12):617-20.
Bertoni F, Present D, Sudanese A, Baldini N, Bacchini P, Campanacci M. Giant-cell tumor of bone with pulmonary metastases. Six case reports and a review of the literature. Clin Orthop Relat Res. 1988(237):275-85.
Campanacci M, Giunti A, Olmi R. Giant-cell tumours of bone: a study of 209 cases with long term follow up in 130. Ital J Orthop Traumatol. 1975;1:247-77.
Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69(1):106-14.
Errani C, Tsukamoto S, Leone G, Righi A, Akahane M, Tanaka Y, Donati DM. Denosumab may increase the risk of local recurrence in patients with giant-cell tumor of bone treated with curettage.J Bone Joint Surg Am. 2018;100(6):496-504.
Vidyadhara S, Rao SK. Techniques in the management of juxta-articular aggressive and recurrent giant cell tumors around the knee. Eur J Surg Oncol. 2007;33:243-51.
Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Recurrent giant cell tumor of long bones: analysis of surgical management. Clin Orthop Relat Res. 2011;469:1181-7
Arbeitsgemeinschaft Knochentumoren, Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy L, Matejovsky Z, Szendroi M, Trieb K, Tunn PU. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am. 2008;90:1060-7.
Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008;134:969-78.
Lackman RD, Hosalkar HS, Ogilvie CM, Torbert JT, Fox EJ. Intralesional curettage for grades II and III giant cell tumors of bone. Clin Orthop Relat Res. 2005;438:123-7.
Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS. Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am. 1999;81:811-20.
Goldenberg RR, Campbell CJ, Bonfiglio M. Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J Bone Joint Surg Am. 1970;52:619-64.
Algawahmed H, Turcotte R, Farrokhyar F, Ghert M. High-speed burring with and without the use of surgical adjuvants in the intralesional management of giant cell tumor of bone: a systematic review and meta-analysis. Sarcoma 2010;2010:586090.
Malek F, Krueger P, Hatmi ZN, Malayeri AA, Faezipour H, O'Donnell RJ. Local control of long bone giant cell tumor using curettage, burring and bone grafting without adjuvant therapy. Int Orthop. 2006;30:495-8.
Zuo D, Zheng L, Sun W, Fu D, Hua Y, Cai Z. Contemporary adjuvant polymethyl methacrylate cementation optimally limits recurrence in primary giant cell tumor of bone patients compared to bone grafting: a systematic review and meta-analysis. World J Surg Oncol. 2013;11:156.
Nelson DA, Barker ME, Hamlin BH. Thermal effects of acrylic cementation at bone tumour sites. Int J Hyperthermia. 1997;13:287-306.
Yu XC, Xu M, Song RX, Fu ZH, Liu XP. Long-term outcome of giant cell tumors of bone around the knee treated by en bloc resection of tumor and reconstruction with prosthesis. Orthop Surg. 2010;2(3):211-7.
Abdel MP, Parratte S, Budhiparama NC. The patella in total knee arthroplasty: to resurface or not is the question. Curr Rev Musculoskelet Med. 2014;7(2):117-24.
Bracey DN, Brown ML, Beard HR, Mannava S, Nazir OF, Seyler TM, Lang JE. Effects of patellofemoral overstuffing on knee flexion and patellar kinematics following total knee arthroplasty: a cadaveric study. Int Orthop. 2015;39(9):1715-22.
Farfalli GL, Slullitel PA, Muscolo DL, Ayerza MA, Aponte-Tinao LA. What happens to the articular surface after curettage for epiphyseal chondroblastoma? A report on functional results, arthritis, and arthroplasty. Clin Orthoprelat Res. 2017;475(3):760-6.
Aboulafia AJ, Rosenbaum DH, Sicard-Rosenbaum L, Jelinek JS, Malawer MM. Treatment of large subchondral tumors of the knee with cryosurgery and composite reconstruction. Clin Orthop Relat Res. 1994;(307):189-99.
Sawa M, Nakasa T, Ikuta Y, Yoshikawa M, Tsuyuguchi Y, Kanemitsu M, Ota Y, Adachi N. Outcome of autologous bone grafting with preservation of articular cartilage to treat osteochondral lesions of the talus with large associated subchondral cysts. Bone Joint J. 2018;100-B(5):590-5.
Tsuchiya H, Abdel-Wanis ME, Tomita K. Biological reconstruction after excision of juxta-articular osteosarcoma around the knee: a new classification system. Anticancer Res. 2006;26(1B):447-53.
Muramatsu K, Ihara K, Taguchi T. Treatment of giant cell tumor of long bones: clinical outcome and reconstructive strategy for lower and upper limbs. Orthopedics. 2009;2(7):491.
Ayerza MA, Aponte-Tinao LA, Farfalli GL, Restrepo CA, Muscolo DL. Joint preservation after extensive curettage of knee giant cell tumors. Clin Orthop Relat Res. 2009;467:2845-51.
von Steyern FV, Kristiansson I, Jonsson K, Mannfolk P, Heinegård D, Rydholm A. Giant-cell tumour of the knee: the condition of the cartilage after treatment by curettage and cementing. J Bone Joint Surg Br. 2007;89(3):361-5.
Ma JX, He WW, Kuang MJ, Sun L, Lu B, Wang Y, Ma XL. Efficacy of bicompartmental knee arthroplasty (BKA) for bicompartmental knee osteoarthritis: a meta analysis. Int J Surg. 2017;46:53-60.
Sabatini L, Giachino M, Risitano S, Atzori F. Bicompartmental knee arthroplasty. Ann Transl Med. 2016;4(1):5.
Parratte S, Ollivier M, Lunebourg A, Abdel MP, Argenson JN. Long-term results of compartmental arthroplasties of the knee: long term results of partial knee arthroplasty. Bone Joint J. 2015;97-B(10 suppl A):9-15.
Potter GD, Abdel MP, Lewallen DG, Hanssen AD. Midterm results of porous tantalum femoral cones in revision total knee arthroplasty. J Bone Joint Surg Am. 2016;98(15):1286-91
Nikolaus OB, Abdel MP, Hanssen AD, Lewallen DG. Porous tantalum femoral metaphyseal cones for large femoral bone defects in revision total knee arthroplasty. JBJS Essent Surg Tech. 2017;7(2):e17.
Divano S, Cavagnaro L, Zanirato A, Basso M, Felli L, Formica M. Porous metal cones: gold standard for massive bone loss in complex revision knee arthroplasty? A systematic review of current literature. Arch Orthop Trauma Surg. 2018;138(6):851-63.
Kim EG, Patel NK, Chughtai M, Elmallah RD, Delanois RE, Harwin SF, Mont MA. Tantalum cones in revision total knee arthroplasty. J Knee Surg. 2016;29(8):621-6.
Natarajan MV, Prabhakar R, Mohamed SM, Shashidhar R. Management of juxta articular giant cell tumors around the knee by custom mega prosthetic arthroplasty. Indian J Orthop. 2007;41(2):134-8.